These results suggested that the hub genes AKT1, TP53, CTNNB1, STAT3, EGFR, VEGFA, PIK3CA, ERBB2, and HIF1A may show a potential involvement in the treatment of glioma with SHD. The gene discussed is AKT1; the disease is central nervous system cancer.